Low Back Pain Clinical Trial
Official title:
Efficacy, Safety, and Tolerability of GRT6005 in Subjects With Moderate to Severe Chronic Low Back Pain.
Verified date | July 2021 |
Source | Tris Pharma, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this trial is to evaluate the safety and efficacy of once daily orally administered GRT6005 in a total of 3 fixed doses compared to placebo in subjects with moderate to severe chronic Low Back Pain (LBP). The study includes a maximum of 21 days screening period followed by a 2-week titration period and 12-week maintenance double-blind treatment period and a 10-14 day safety follow up period. Patients who are eligible for the double-blind treatment period will be randomized to one of the following treatment groups: GRT6005 low-dose, GRT6005 medium dose, GRT6005 high-dose, Tapentadol or placebo.
Status | Completed |
Enrollment | 1089 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Chronic Low Back Pain of non-malignant origin and present for at least 3 months. - Signed informed consent. - Pain intensity score of 5 or greater on the 11-point numeric rating scale (where 0 indicates "no pain" and 10 indicates "as bad as you can imagine"). - On stable analgesic medications (non-opioid and/or opioid medications) for chronic low back pain with regular intake for at least 3 months and dissatisfied with current analgesic treatment. Exclusion Criteria: - Female subjects who are pregnant or are breastfeeding. - Presence of risk factors for Torsade de Pointes. - Any clinically significant disease or laboratory findings that may affect efficacy or safety assessments or may compromise the safety during trial participation, e.g., significant unstable cardiac, vascular, pulmonary, gastrointestinal, endocrine, metabolic, neurological, or psychiatric disorders. - History of acute hepatitis within the past 3 months or chronic hepatitis or a positive result on anti-hepatitis A antibody, hepatitis B surface antigen, or anti-hepatitis C antibody. History of human immunodeficiency virus (HIV) infection. - History of seizure disorder. - Chronic low back pain potentially associated with a specific spinal cause. - Surgery or painful procedure during or within 3 months of enrollment. - Conditions that contribute and confound the assessment of pain. - Subjects with impaired renal function. - Subjects with impaired hepatic functionality. - Neuromodulation. - Cancer. - Clinically relevant history of hypersensitivity, allergy or contraindications to any of the Investigational Medicinal Products' excipients, paracetamol/acetaminophen, tapentadol Hydrochloride, or opioid analgesics (or excipients). |
Country | Name | City | State |
---|---|---|---|
Austria | AT003 | Senftenberg | |
Austria | AT001 | Wien | |
Austria | AT004 | Wien | |
Austria | AT005 | Wien | |
Austria | AT006 | Wien | |
Belgium | BE001 | Bruxelles | |
Belgium | BE002 | Edegem | |
Belgium | BE004 | Genk | |
Denmark | DK004 | Aalborg | |
Denmark | DK001 | Frederiksberg | |
Denmark | Site DK002 | Glostrup | |
Denmark | DK003 | Odense | |
Finland | FI005 | Kokkola | |
Finland | FI001 | Kuopio | |
Finland | FI003 | Lahti | |
Germany | DE005 | Bad Nauheim | |
Germany | DE014 | Berlin | |
Germany | DE018 | Berlin | |
Germany | DE011 | Bochum | |
Germany | DE015 | Böhlen | |
Germany | DE007 | Dresden | |
Germany | DE016 | Essen | |
Germany | DE001 | Hamburg | |
Germany | DE006 | Hamburg | |
Germany | DE008 | Hannover | |
Germany | DE002 | Leipzig | |
Germany | DE019 | Leipzig | |
Germany | DE009 | Mosbach | |
Germany | DE004 | Munich | |
Germany | DE013 | Rodgau | |
Germany | DE017 | Wiesbaden | |
Hungary | HU010 | Baja | |
Hungary | HU008 | Békéscsaba | |
Hungary | HU005 | Budapest | |
Hungary | HU011 | Budapest | |
Hungary | HU012 | Budapest | |
Hungary | HU015 | Budapest | |
Hungary | HU003 | Kecskemet | |
Hungary | HU002 | Kiskunfélegyháza | |
Hungary | HU001 | Mako | |
Hungary | HU009 | Nagykanizsa | |
Hungary | HU014 | Nyiregyhaza | |
Hungary | HU004 | Szekszárd | |
Netherlands | NL003 | Almere | |
Netherlands | NL002 | Eindhoven | |
Netherlands | NL005 | Tiel | |
Poland | PL002 | Elblag | |
Poland | PL006 | Gdynia | |
Poland | PL015 | Gdynia | |
Poland | PL001 | Katowice | |
Poland | PL014 | Katowice | |
Poland | PL008 | Krakow | |
Poland | PL011 | Krakow | |
Poland | PL013 | Krakow | |
Poland | PL009 | Lublin | |
Poland | PL016 | Poznan | |
Poland | PL018 | Poznan | |
Poland | PL004 | Warszawa | |
Poland | PL012 | Warszawa | |
Poland | PL010 | Wroclaw | |
Poland | PL017 | Wroclaw | |
Poland | PL005 | Zgierz | |
Spain | ES002 | Barcelona | |
Spain | ES006 | Barcelona | |
Spain | ES004 | La Coruna | |
Spain | ES001 | Madrid | |
Spain | ES013 | Madrid | |
Spain | ES008 | Málaga | |
Spain | ES003 | Oviedo | |
Spain | ES011 | Oviedo | |
Spain | ES005 | Santiago de Compostela | |
Spain | ES007 | Sevilla | |
Sweden | SE001 | Skene | |
Sweden | SE002 | Stockholm | |
Sweden | SE004 | Vällingby | |
United Kingdom | GB002 | Liverpool | |
United Kingdom | GB005 | London | |
United Kingdom | GB003 | Manchester | |
United Kingdom | GB004 | Plymouth |
Lead Sponsor | Collaborator |
---|---|
Tris Pharma, Inc. | Forest Laboratories |
Austria, Belgium, Denmark, Finland, Germany, Hungary, Netherlands, Poland, Spain, Sweden, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | European Union: the change from baseline pain to the weekly average 24-hour pain during the entire 12 weeks of the maintenance phase of the double-blind Treatment Period. | Baseline to End of Treatment (Week 14) | ||
Primary | United States: the change from baseline pain to the average 24-hour pain during Week 12 of the maintenance phase. | Baseline to End of Treatment (Week 14) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03916705 -
Thoraco-Lumbar Fascia Mobility
|
N/A | |
Completed |
NCT04007302 -
Modification of the Activity of the Prefrontal Cortex by Virtual Distraction in the Lumbago
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT03600207 -
The Effect of Diaphragm Muscle Training on Chronic Low Back Pain
|
N/A | |
Completed |
NCT04284982 -
Periodized Resistance Training for Persistent Non-specific Low Back Pain
|
N/A | |
Recruiting |
NCT05600543 -
Evaluation of the Effect of Lumbar Belt on Spinal Mobility in Subjects With and Without Low Back Pain
|
N/A | |
Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
Completed |
NCT03673436 -
Effect of Lumbar Spinal Fusion Predicted by Physiotherapists
|
||
Completed |
NCT02546466 -
Effects of Functional Taping on Static Postural Control in Patients With Non-specific Chronic Low Back Pain
|
N/A | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05156242 -
Corticospinal and Motor Behavior Responses After Physical Therapy Intervention in Patients With Chronic Low Back Pain.
|
N/A | |
Recruiting |
NCT04673773 -
MY RELIEF- Evidence Based Information to Support People Aged 55+ Years Living and Working With Persistent Low-back Pain.
|
N/A | |
Completed |
NCT06049277 -
Mulligan Technique Versus McKenzie Extension Exercise Chronic Unilateral Radicular Low Back Pain
|
N/A | |
Completed |
NCT06049251 -
ELDOA Technique Versus Lumbar SNAGS With Motor Control Exercises
|
N/A | |
Completed |
NCT04980469 -
A Study to Explore the Effect of Vitex Negundo and Zingiber Officinale on Non-specific Chronic Low Back Pain Due to Sedentary Lifestyle
|
N/A | |
Completed |
NCT04055545 -
High Intensity Interval Training VS Moderate Intensity Continuous Training in Chronic Low Back Pain Subjects
|
N/A | |
Recruiting |
NCT05944354 -
Wearable Spine Health System for Military Readiness
|
||
Recruiting |
NCT05552248 -
Assessment of the Safety and Performance of a Lumbar Belt
|
||
Completed |
NCT05801588 -
Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life
|
N/A | |
Completed |
NCT05811143 -
Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.
|